Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | ||||
| Cash paid | -15.56%-1.46M | 16.92%-1.26M | -5.46%-1.52M | -1.44M |
| Payments to suppliers for goods and services | -15.56%-1.46M | 16.92%-1.26M | -5.46%-1.52M | ---1.44M |
| Operating cash flow | -15.56%-1.46M | 16.92%-1.26M | -5.46%-1.52M | ---1.44M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | -382.78%-2.89M | 81.75%-597.96K | -3.58%-3.28M | -3.16M |
| Capital expenditure reported | -389.19%-2.91M | 81.94%-593.98K | -4.30%-3.29M | ---3.15M |
| Net PPE purchase and sale | ---6K | ---- | 79.47%-2.3K | ---11.2K |
| Net investment purchase and sale | 25.37%-6.27K | 83.17%-8.4K | ---49.93K | ---- |
| Interest received (cash flow from investment activities) | 604.75%31.14K | -88.93%4.42K | 2,319.09%39.92K | --1.65K |
| Cash from discontinued investing activities | ||||
| Investing cash flow | -382.78%-2.89M | 81.75%-597.96K | -3.58%-3.28M | ---3.16M |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | 104.55%5.24M | 9,620.60%2.56M | -100.28%-26.89K | 9.61M |
| Net common stock issuance | 101.45%5.33M | 9,932.74%2.64M | -100.28%-26.89K | --9.61M |
| Net other financing activities | 46.46%-89.88K | -524.28%-167.87K | ---26.89K | ---- |
| Cash from discontinued financing activities | ||||
| Financing cash flow | 104.55%5.24M | 9,620.60%2.56M | -100.28%-26.89K | --9.61M |
| Net cash flow | ||||
| Beginning cash position | 103.72%1.4M | -87.49%689.41K | 1,149.86%5.51M | --440.78K |
| Current changes in cash | 27.34%889.5K | 114.48%698.53K | -196.41%-4.82M | --5M |
| Effect of exchange rate changes | -104.18%-690 | 266.91%16.5K | -93.03%4.5K | --64.48K |
| End cash Position | 63.29%2.29M | 103.72%1.4M | -87.49%689.41K | --5.51M |
| Free cash from | -135.36%-4.37M | 61.40%-1.86M | -4.46%-4.81M | ---4.61M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |